Bashir Shihabuddin

Professor

UAMS

Last publication 2021 Last refreshed 2026-04-18

faculty

Neurology, College of Medicine

8 h-index 20 pubs 214 cited

Research Areas

Links

Research Group UAMS TRI Profile

OverviewAI-generated summary

Bashir Shihabuddin's research focuses on the study of neurological disorders, particularly in relation to electroencephalography (EEG) and magnetoencephalography (MEG). He has investigated autoimmune encephalitis and its association with seizures, examining findings from cerebrospinal fluid, imaging, and EEG. His work also explores the relationship between changes in EEG activity and a decrease in tinnitus awareness following repetitive transcranial magnetic stimulation (rTMS). Shihabuddin has published 20 papers, accumulating 200 citations, and holds an h-index of 8. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Abdallah Hayar, John L. Dornhoffer, Kalpana P. Padala, and Edgar García‐Rill. His recent activity indicates ongoing engagement in his field.

Metrics

h-index: 8
Publications: 20
Citations: 214

Selected Publications

Autoimmune encephalitis and seizures, cerebrospinal fluid, imaging, and EEG findings: a case series (2021)

14 citations DOI OpenAlex
Change in EEG Activity is Associated with a Decrease in Tinnitus Awareness after rTMS. (2021)

6 citations OpenAlex

View all publications on OpenAlex →

Grants & Funding

An International, double-blind, randomized, multi-center, parallel group, historical-control conversion to monotherapy study to evaluate the efficacy UCB BioSciences, Inc. Principal Investigator
RII Track-2 FEC- Probing and Understanding the Brain: Micro and Macro Dynamics of Seizure and Memory Networks - Continuation - Continuation - Continuation National Science Foundation - Pass Through: Louisiana Tech University Co-Investigator
SP0982 UCB BioSciences, Inc. Principal Investigator
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Three-Arm, Parallel Group Study to Evaluate the Efficacy and Safety of Oxcarbazepine Extend Supernus Pharmaceuticals, Inc. Principal Investigator
Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Oxcarbazepine Extended-Release (OXC XR) as Adjunctive The Supernus Pharmaceuticals, Inc. Principal Investigator
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER TRIAL OF PREGABALIN CR AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH PARTI Pfizer, Inc. Principal Investigator
Prospective Randomized 12-Weeks Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin of Placebo Pfizer, Inc. Principal Investigator
Development of Analysis Tools to Enhance Fetal Neurological Assessment NIH Co-Investigator